tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Janux Therapeutics price target lowered to $49 from $58 at BofA
PremiumThe FlyJanux Therapeutics price target lowered to $49 from $58 at BofA
1M ago
Buy Rating Reaffirmed for JANX007 Amid Promising Survival Metrics and Competitive Positioning
Premium
Ratings
Buy Rating Reaffirmed for JANX007 Amid Promising Survival Metrics and Competitive Positioning
1M ago
Buy Rating Affirmed for JANX007 Amid Promising Phase 1 Data and Market Dislocation
Premium
Ratings
Buy Rating Affirmed for JANX007 Amid Promising Phase 1 Data and Market Dislocation
1M ago
Promising Clinical Trial Results and Strong Financial Position Drive Buy Rating for Janux Therapeutics Inc.
PremiumRatingsPromising Clinical Trial Results and Strong Financial Position Drive Buy Rating for Janux Therapeutics Inc.
2M ago
Closing Bell Movers: MongoDB jumps 22% on earnings beat and raise
Premium
The Fly
Closing Bell Movers: MongoDB jumps 22% on earnings beat and raise
2M ago
Janux Therapeutics down 46% at $18.50 after JANX007 Phase 1 data in mCRPC
Premium
The Fly
Janux Therapeutics down 46% at $18.50 after JANX007 Phase 1 data in mCRPC
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100